ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,06995
-0,17%
Bitcoin
66.348,10
-0,44%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sagiment Biosciences Inc (SGMT)

  7. Sagiment Biosciences Inc (SGMT) News

SGMT

Sagiment Biosciences (SGMT)

Sagiment Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SGMT
DatumZeitQuelleÜberschriftSymbolFirma
13/06/202412h07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
07/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
07/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/06/202412h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
23/05/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
15/05/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
15/05/202413h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGMTSagiment Biosciences Inc
08/05/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
08/05/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/05/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
25/03/202412h00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:SGMTSagiment Biosciences Inc
25/03/202411h15GlobeNewswire Inc.Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
29/02/202414h00GlobeNewswire Inc.Sagimet Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:SGMTSagiment Biosciences Inc
15/02/202400h10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
14/02/202422h37Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
05/02/202422h34Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
02/02/202422h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
02/02/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
31/01/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
31/01/202422h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
30/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
26/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGMTSagiment Biosciences Inc
26/01/202402h58GlobeNewswire Inc.Sagimet Biosciences Announces Pricing of Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
24/01/202412h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
24/01/202412h08Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
23/01/202423h45GlobeNewswire Inc.Sagimet Biosciences Announces Proposed Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
23/01/202423h31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SGMTSagiment Biosciences Inc
22/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
22/01/202413h00GlobeNewswire Inc.Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASHNASDAQ:SGMTSagiment Biosciences Inc
29/12/202322h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SGMT

Kürzlich von Ihnen besucht

NASDAQ
APXT
Apex Technology Acquisit...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten